Deanna Angello Email and Phone Number
Deanna Angello work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Deanna Angello personal email
- Valid
Deanna Angello phone numbers
Dynamic biotech commercial leader and investor with strategic and operations expertise via senior roles with Pfizer, Genentech, Johnson & Johnson and Kite. Spearheaded 7 drug launches and lifecycle growth to $7B in annual revenues. Knowing that better patient outcomes lead to profitability inspires my proven, patient-centric approach to drive long-term value and revenue for effective treatments. I am known as an effective product and organizational leader. I’ve positively changed the trajectory of blockbuster drugs, shifted mindsets and built capabilities to enable businesses to evolve for more competitive and dynamic environments.CEOs and Board members say I “see around corners” via my big picture POV and my ability to stay ahead of industry trends. I transform and inspire organizations in need of innovation, see opportunities and new ideas in obstacles and can make the impossible possible, even with limited resources. A key to my success: I’m a commercial leader with a “bench to bedside” mindset. I put the patient first. I uniquely bridge the clinical and commercial phases using a three-pronged approach to transform lab innovations to deliver better patient outcomes:🔶 Ecosystem Relationships: developing trust-based relationships with the entire ecosystem – from academia, entrepreneurs, investors, government to industry and all the other stakeholders throughout the process.🔶 Cross-Functional Strategic Leadership: bringing a range of experts to the table to gain a 360-degree perspective and develop holistic strategies.🔶 Data-Driven Execution: using patient and customer insights to inform all phases, and agile execution to drive growth.I stay close to industry trends as an angel investor in the health care sector, and as a mentor by steering early-stage companies through commercialization to ensure successful market entry of new therapies and technologies. As a consultant and advisor in the past year, I’ve helped early-stage healthcare companies secure $20M in funding and have positioned them for marketplace success. As an Executive-in-Residence with Springboard Enterprises, I’ve played a leading role in guiding women-led life sciences and health tech ventures by leveraging industry relationships and providing critical commercialization insights.My passion for better healthcare stems from personal experience. When my dad was diagnosed with a rare neurodegenerative disease, I saw firsthand the need to re-write the rules of healthcare. Today, my passion and life’s purpose are making healthcare more effective, efficient and more human.
Springboard Enterprises
View-
Executive In Residence, Life Sciences & TechnologySpringboard Enterprises Mar 2024 - PresentMclean, Virginia, UsRecruited to company with a charter to provide mentorship to Seed to Series A company CEOs and to serve as an acting Chief Commercial Officer providing business strategy guidance to preclinical, clinical, and early-stage healthcare companies on about clinical development, navigating the healthcare ecosystem, scaling the business, and growth strategies. Accountable for designing and implementing a comprehensive accelerator program that promotes market readiness and makes introductions to industry contacts across life sciences, biopharma, and investors to facilitate funding opportunities and strategic partnerships for CEOs.Key Accomplishments:● Secured a total of $20 million in seed funding and contracts from angel investors and high net worth individuals.● Generated a 30% increase in investor interest by mentoring over 25 early-stage CEOs and Founders and conducting 40+ one-on-one coaching sessions to refine business strategies.● Developed and executed Go-To-Market (GTM) strategies for 10 pre-revenue (and preclinical) products and technologies, positioning them for successful market entry and future revenue generation. -
Life Sciences Executive Council & Digital Health AdvisorSpringboard Enterprises Jul 2022 - PresentMclean, Virginia, Us -
Investing Member, Active Aging & Longevity Fund IiPortfolia Sep 2023 - PresentSan Mateo, Ca, UsActively participating in monthly pitch calls and due diligence for potential investments in diseases related to aging and solutions for ensuring greater longevity and health span.Portfolia is the world’s most powerful network of women investing in the companies we want in the world for returns and impact. -
Head Of Oncology Franchise Marketing, Commercial Strategy & Key Account ManagementThe Janssen Pharmaceutical Companies Of Johnson & Johnson Jun 2021 - Oct 2022Raritan, New Jersey, UsRecruited by J&J’s President of the $6B Oncology unit to lead the transition from primary care to a specialty-focused customer engagement model, emphasizing Key Account Management and strategic partnerships. Led three product launches across five Commercial functions—Franchise Strategy, Digital/Omnichannel, Patient Services, Key Account Management, and Clinical Nurse Educators. Accountable for driving three of the President’s top five growth initiatives to advance the oncology portfolio and improve patient outcomes. Oversaw a team of 100+ and managed a $35M budget for a portfolio including Darzalex®, Erleada®, Imbruvica®, Rybrevant®, Carvykti®, Tecvayli®, and Balversa®. Key Accomplishments:● Accountable for driving success and share on three new product launches: Rybrevant, Carvykti and Tecvayli. ● 15% increase in product adoption of current commercial products and strengthened partnership with Key Accounts by securing two major pathway wins at leading oncology key accounts. ● Generated a 20% increase in HCP engagement and a 10% boost in sales by executing an innovative omnichannel strategy that included integrated AI marketing and digital transformation.● Improved customer engagement by launching two pilots to establish long-term strategic partnerships with leading cancer centers, hospitals, and oncology networks to expand access and enhance adoption of cutting-edge oncology therapies. -
Executive Director, Business Strategy & Operations L Chief Of Staff To CeoKite Pharma Oct 2020 - Jun 2021Santa Monica, California, UsRecruited by the newly hired CEO to lead the development and execution of Kite’s enterprise growth strategy for Yescarta and Tectarus and to establish and lead the governance for the executive team and execution of the CEO priorities and agenda. Accountable for leading a change management charter to support the enterprise growth strategy to deliver a business plan focused on streamlining operations, determining R&D priorities, and delivering on a roadmap for building capabilities to transform from a high growth startup into a sustainable mid-sized biotech. Key Accomplishments:● Worked with the C-suite to streamline decision making, the R&D pipeline priorities and to focus on upskilling this cell therapy organization and its commercialization efforts.● Improved organizational efficiency and identified priorities by creating an Executive Forum for the functional leadership. -
Us Launch Lead, Alzheimer'S Portfolio & Neuroscience Pipeline ManagementGenentech Feb 2018 - Jun 2019South San Francisco, California, Usassets: Ph III crenezumab and gantenerumab and two PhII assets in clinical trials. Accountable for leading the commercial strategy, value and pricing, market access, business insights and analytics for primary and specialty care markets for two PIII programs which had the potential to be disease-modifying (DM) therapies with $10B in revenue (failed in PhIII). Additional accountabilities for go/no-go decisions in pipeline and business development & licensing for earlier stage assets. Led Alzheimer’s pre-launch market shaping and launch planning. Built the first cross-functional team to create and execute a cohesive strategy for the first AD DM drug. Developed an organizational structure and capabilities launch plan essential for bringing transformative science to market.Key Accomplishments:● Worked closely with the top global neurodegeneration KOLs on market development initiatives to gain alignment on the definition of disease modifying features and benefits. Recognized by senior management for this innovative market development program which is now a best practice for the organization.● Engaged the Payors in developing innovative risk sharing reimbursement strategies that were based on shared risk and patient outcomes for this potentially transformative Alzheimer’s therapy. -
Head, Oncology Marketing & Commercial StrategyGenentech Mar 2015 - Feb 2018South San Francisco, California, UsRecruited to lead the development of the corporate strategy and market development plan for Genentech’s Oncology portfolio which included: Herceptin, Rituxan, and Avastin which represented over $10B in company revenue – the largest competitive threat in their history. Executed a charter to help the company address the new entry of biosimilars in the US. Accountable for working across the broader Genentech/Roche enterprise to build out the capability of marketing excellence to enable the entire commercial organization to be more competitive in this new landscape for biologics. Led a nimble team of 12. -
Board Of DirectorsThe Association For Frontotemporal Degeneration Apr 2012 - May 2018King Of Prussia, Pa, Us● Led Marketing Strategy Task Force including the development of a comprehensive strategy defining value proposition and message platform to advance awareness. o Increased Website visitors by 427%; Doubled number of Donations● Selected for Strategic Planning Task Force and led Board through evolved vision, strategic and operational planning and prioritization of initiatives and investments.● Personally raised over $50K for clinical research -
Multiple Marketing & Commercial Leadership Roles - Lyrica, Lipitor, Exubera, AriceptPfizer May 2003 - Mar 2015New York, New York, UsGained extensive industry experience in progressive roles of responsibility, including brand marketing, new product planning, market research and analytics, and business development across multi-billion-dollar brands. Worked in lifecycle management, market development, pre-launch, launch to peri-LOE. Key Accomplishments:● Revitalized $3B product, delivering 10% revenue growth by creating multi-specialists and PCP marketing strategies. Turned around double-digit decline in less than 1 year by collaborating with 5 Regional Presidents and marketers to train 2K commercial staff on customer-centric approach in less than 6 weeks, a 50% decrease in execution time. ● Reinvigorated sales force by developing distinctive message platform including creation of target patient types, resulting in increased SOV over competition and renewed product growth, driving sales 10%.● Delivered 15% market share growth by identifying key insights, leading to significant repositioning in brand strategy and solidifying brand’s competitive advantages. -
Senior Consultant, Organization And Process Improvement PracticeBooz Allen Hamilton 2001 - 2002Mclean, Va, UsLed engagement that resulted in repeat business. Spearheaded survey development, deployment and analysis as member of NCIS team; findings led to new $400M contract for business process improvement and change initiative● Strengthened internal capacity by with gap analysis of firm’s Commercial and Public Sector consulting arms and integrating sector-independent training courses. Created unified Center of Excellence for Professional Development -
Consultant, Healthcare And National Intelligence PracticesKpmg Consulting 1998 - 2001Amsterdam, NlSupported clients in strategy development, operations, business planning and process improvement.● Key member on pilot for Centers for Disease Control helping firm break into healthcare market securing future work.● Led three analysts in the revision of regulatory and data policies for the Centers for Medicare and Medicaid Services (CMS) web-based Medicare appeals database which lead to 20% improvement in efficiency and processing rate.
Deanna Angello Skills
Deanna Angello Education Details
-
Indiana University - Kelley School Of BusinessFinance & Strategic Management -
University Of PittsburghPsychology -
University Of St.GallenGeneral
Frequently Asked Questions about Deanna Angello
What company does Deanna Angello work for?
Deanna Angello works for Springboard Enterprises
What is Deanna Angello's role at the current company?
Deanna Angello's current role is Biotech Commercial Leader l Patient-Centric l Catalyst l Investor & Advisor.
What is Deanna Angello's email address?
Deanna Angello's email address is an****@****ene.com
What is Deanna Angello's direct phone number?
Deanna Angello's direct phone number is +191723*****
What schools did Deanna Angello attend?
Deanna Angello attended Indiana University - Kelley School Of Business, University Of Pittsburgh, University Of St.gallen.
What skills is Deanna Angello known for?
Deanna Angello has skills like Strategy, Pharmaceutical Industry, Analytics, Strategic Planning, Business Development, Marketing Strategy, Market Analysis, Market Research, Strategic Partnerships, Competitive Analysis, Leadership, Management.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial